Steven Bray

Background

About Steven Bray

Dr. Steven Bray is an experienced scientist and leader with 15+ years in academia, pharma, and the biotech industry. He has led diverse teams of geneticists, bioinformaticians, lab scientists, and software engineers to drive advancements in genomics, cancer genetics, molecular biology, and precision health. With a focus on personalized medicine, Dr. Bray is passionate about integrating genomics and multimodal data to shape the future of health, targeting both prevention and intervention strategies for individuals.After earning a Ph.D. in genetics from Duke University, followed by a postdoctoral fellowship in human genetics at Emory University, Dr. Bray joined Eli Lilly as a cancer genetics research scientist, where he led biomarker identification efforts to predict drug response. At LifeOmic, he spearheaded multi-omic data integration for precision oncology, helping clinicians tailor treatments to individual patients. Following LifeOmic’s merger with Fountain Life, he broadened his research by integrating imaging and biomarker data, advancing early disease detection and proactive interventions—cornerstones of precision medicine’s shift toward predictive, preventative, and personalized care.